2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole

C264H160N32O4 — CID 160640192

IUPAC2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole
SMILESc1ccc(-c2ccc(-c3ccnc(-c4cccc(-n5c6ccccc6c6ccc(-c7nnc(-c8ccc9c%10ccccc%10n(-c%10cccc(-c%11nccc(-c%12ccc(-c%13ccccc%13)cc%12)n%11)c%10)c9c8)o7)cc65)c4)n3)cc2)cc1.c1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9nc(-c%10ccc(-c%11ccccc%11)cc%10)c%10ccccc%10n9)c8c7)o6)cc54)nc4ccccc34)cc2)cc1.c1ccc(-c2nc(-n3c4ccccc4c4ccc(-c5nnc(-c6ccc7c8ccccc8n(-c8nc(-c9ccccc9)c9ccccc9n8)c7c6)o5)cc43)nc3ccccc23)cc1.c1ccc2c(-c3ccc(-c4nc(-n5c6ccccc6c6ccc(-c7nnc(-c8ccc9c%10ccccc%10n(-c%10nc(-c%11ccc(-c%12cccc%13ccccc%12%13)cc%11)c%11ccccc%11n%10)c9c8)o7)cc65)nc5ccccc45)cc3)cccc2c1
InChIInChI=1S/C74H44N8O.C70H44N8O.C66H40N8O.C54H32N8O/c1-3-19-53-45(15-1)17-13-25-55(53)47-31-35-49(36-32-47)69-61-23-5-9-27-63(61)75-73(77-69)81-65-29-11-7-21-57(65)59-41-39-51(43-67(59)81)71-79-80-72(83-71)52-40-42-60-58-22-8-12-30-66(58)82(68(60)44-52)74-76-64-28-10-6-24-62(64)70(78-74)50-37-33-48(34-38-50)56-26-14-18-46-16-2-4-20-54(46)56;1-3-13-45(14-4-1)47-25-29-49(30-26-47)61-37-39-71-67(73-61)51-17-11-19-55(41-51)77-63-23-9-7-21-57(63)59-35-33-53(43-65(59)77)69-75-76-70(79-69)54-34-36-60-58-22-8-10-24-64(58)78(66(60)44-54)56-20-12-18-52(42-56)68-72-40-38-62(74-68)50-31-27-48(28-32-50)46-15-5-2-6-16-46;1-3-15-41(16-4-1)43-27-31-45(32-28-43)61-53-21-7-11-23-55(53)67-65(69-61)73-57-25-13-9-19-49(57)51-37-35-47(39-59(51)73)63-71-72-64(75-63)48-36-38-52-50-20-10-14-26-58(50)74(60(52)40-48)66-68-56-24-12-8-22-54(56)62(70-66)46-33-29-44(30-34-46)42-17-5-2-6-18-42;1-3-15-33(16-4-1)49-41-21-7-11-23-43(41)55-53(57-49)61-45-25-13-9-19-37(45)39-29-27-35(31-47(39)61)51-59-60-52(63-51)36-28-30-40-38-20-10-14-26-46(38)62(48(40)32-36)54-56-44-24-12-8-22-42(44)50(58-54)34-17-5-2-6-18-34/h1-44H;1-44H;1-40H;1-32H
InChIKeyRJBPPSBZHUYXGF-UHFFFAOYSA-N
MW3844.40 g/mol
LogP64.61
Rot. Bonds32

About 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole

2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole (PubChem CID 160640192) has the molecular formula C264H160N32O4 and a molecular weight of 3844.40 g/mol. Its IUPAC name is 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole.

Molecular Properties

Compound Name2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole
PubChem CID160640192
Molecular FormulaC264H160N32O4
Molecular Weight3844.40 g/mol
Exact Mass3841.33
IUPAC Name2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole
SMILESc1ccc(-c2ccc(-c3ccnc(-c4cccc(-n5c6ccccc6c6ccc(-c7nnc(-c8ccc9c%10ccccc%10n(-c%10cccc(-c%11nccc(-c%12ccc(-c%13ccccc%13)cc%12)n%11)c%10)c9c8)o7)cc65)c4)n3)cc2)cc1.c1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9nc(-c%10ccc(-c%11ccccc%11)cc%10)c%10ccccc%10n9)c8c7)o6)cc54)nc4ccccc34)cc2)cc1.c1ccc(-c2nc(-n3c4ccccc4c4ccc(-c5nnc(-c6ccc7c8ccccc8n(-c8nc(-c9ccccc9)c9ccccc9n8)c7c6)o5)cc43)nc3ccccc23)cc1.c1ccc2c(-c3ccc(-c4nc(-n5c6ccccc6c6ccc(-c7nnc(-c8ccc9c%10ccccc%10n(-c%10nc(-c%11ccc(-c%12cccc%13ccccc%12%13)cc%11)c%11ccccc%11n%10)c9c8)o7)cc65)nc5ccccc45)cc3)cccc2c1
InChIInChI=1S/C74H44N8O.C70H44N8O.C66H40N8O.C54H32N8O/c1-3-19-53-45(15-1)17-13-25-55(53)47-31-35-49(36-32-47)69-61-23-5-9-27-63(61)75-73(77-69)81-65-29-11-7-21-57(65)59-41-39-51(43-67(59)81)71-79-80-72(83-71)52-40-42-60-58-22-8-12-30-66(58)82(68(60)44-52)74-76-64-28-10-6-24-62(64)70(78-74)50-37-33-48(34-38-50)56-26-14-18-46-16-2-4-20-54(46)56;1-3-13-45(14-4-1)47-25-29-49(30-26-47)61-37-39-71-67(73-61)51-17-11-19-55(41-51)77-63-23-9-7-21-57(63)59-35-33-53(43-65(59)77)69-75-76-70(79-69)54-34-36-60-58-22-8-10-24-64(58)78(66(60)44-54)56-20-12-18-52(42-56)68-72-40-38-62(74-68)50-31-27-48(28-32-50)46-15-5-2-6-16-46;1-3-15-41(16-4-1)43-27-31-45(32-28-43)61-53-21-7-11-23-55(53)67-65(69-61)73-57-25-13-9-19-49(57)51-37-35-47(39-59(51)73)63-71-72-64(75-63)48-36-38-52-50-20-10-14-26-58(50)74(60(52)40-48)66-68-56-24-12-8-22-54(56)62(70-66)46-33-29-44(30-34-46)42-17-5-2-6-18-42;1-3-15-33(16-4-1)49-41-21-7-11-23-43(41)55-53(57-49)61-45-25-13-9-19-37(45)39-29-27-35(31-47(39)61)51-59-60-52(63-51)36-28-30-40-38-20-10-14-26-46(38)62(48(40)32-36)54-56-44-24-12-8-22-42(44)50(58-54)34-17-5-2-6-18-34/h1-44H;1-44H;1-40H;1-32H
InChIKeyRJBPPSBZHUYXGF-UHFFFAOYSA-N
XLogP64.61
TPSA401.36 Ų
H-Bond Donors
H-Bond Acceptors36
Rotatable Bonds32
Heavy Atoms300
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003844.40
LogP ≤ 564.61
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1036

Analyze 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole?
The IUPAC name of 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole (CID 160640192) is 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole.
What is the SMILES notation for 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole?
The canonical SMILES for 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole is c1ccc(-c2ccc(-c3ccnc(-c4cccc(-n5c6ccccc6c6ccc(-c7nnc(-c8ccc9c%10ccccc%10n(-c%10cccc(-c%11nccc(-c%12ccc(-c%13ccccc%13)cc%12)n%11)c%10)c9c8)o7)cc65)c4)n3)cc2)cc1.c1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9nc(-c%10ccc(-c%11ccccc%11)cc%10)c%10ccccc%10n9)c8c7)o6)cc54)nc4ccccc34)cc2)cc1.c1ccc(-c2nc(-n3c4ccccc4c4ccc(-c5nnc(-c6ccc7c8ccccc8n(-c8nc(-c9ccccc9)c9ccccc9n8)c7c6)o5)cc43)nc3ccccc23)cc1.c1ccc2c(-c3ccc(-c4nc(-n5c6ccccc6c6ccc(-c7nnc(-c8ccc9c%10ccccc%10n(-c%10nc(-c%11ccc(-c%12cccc%13ccccc%12%13)cc%11)c%11ccccc%11n%10)c9c8)o7)cc65)nc5ccccc45)cc3)cccc2c1.
What is the InChIKey of 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole?
The InChIKey is RJBPPSBZHUYXGF-UHFFFAOYSA-N. The full InChI is InChI=1S/C74H44N8O.C70H44N8O.C66H40N8O.C54H32N8O/c1-3-19-53-45(15-1)17-13-25-55(53)47-31-35-49(36-32-47)69-61-23-5-9-27-63(61)75-73(77-69)81-65-29-11-7-21-57(65)59-41-39-51(43-67(59)81)71-79-80-72(83-71)52-40-42-60-58-22-8-12-30-66(58)82(68(60)44-52)74-76-64-28-10-6-24-62(64)70(78-74)50-37-33-48(34-38-50)56-26-14-18-46-16-2-4-20-54(46)56;1-3-13-45(14-4-1)47-25-29-49(30-26-47)61-37-39-71-67(73-61)51-17-11-19-55(41-51)77-63-23-9-7-21-57(63)59-35-33-53(43-65(59)77)69-75-76-70(79-69)54-34-36-60-58-22-8-10-24-64(58)78(66(60)44-54)56-20-12-18-52(42-56)68-72-40-38-62(74-68)50-31-27-48(28-32-50)46-15-5-2-6-16-46;1-3-15-41(16-4-1)43-27-31-45(32-28-43)61-53-21-7-11-23-55(53)67-65(69-61)73-57-25-13-9-19-49(57)51-37-35-47(39-59(51)73)63-71-72-64(75-63)48-36-38-52-50-20-10-14-26-58(50)74(60(52)40-48)66-68-56-24-12-8-22-54(56)62(70-66)46-33-29-44(30-34-46)42-17-5-2-6-18-42;1-3-15-33(16-4-1)49-41-21-7-11-23-43(41)55-53(57-49)61-45-25-13-9-19-37(45)39-29-27-35(31-47(39)61)51-59-60-52(63-51)36-28-30-40-38-20-10-14-26-46(38)62(48(40)32-36)54-56-44-24-12-8-22-42(44)50(58-54)34-17-5-2-6-18-34/h1-44H;1-44H;1-40H;1-32H.
What are the key properties of 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole?
2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole has a molecular weight of 3844.40 g/mol, XLogP of 64.61, 32 rotatable bonds, 0 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[3-[4-(4-phenylphenyl)pyrimidin-2-yl]phenyl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole is sourced from PubChem (CID 160640192), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).